CalciMedica Presents Data From Preclinical Studies Of Auxora On Acute Kidney Injury At 29th International AKI & CRRT Conference
CalciMedica Presents Data From Preclinical Studies Of Auxora On Acute Kidney Injury At 29th International AKI & CRRT Conference
CalciMedica在第29屆國際AKI和CRRT會議上公佈了來自Auxora急性腎損傷臨床前研究的數據
Therapeutic treatment with Auxora shown to hasten the recovery of kidney function and improve survival in a rat model of acute kidney injury (AKI)
事實證明，在急性腎損傷（AKI）大鼠模型中，使用Auxora進行治療可加快腎功能的恢復並提高存活率
Preclinical results are consistent with clinical observations made with Auxora, supporting the KOURAGE trial in patients with severe AKI that will start enrolling in 2Q 2024
臨床前結果與Auxora的臨床觀察結果一致，支持了將於2024年第二季度開始註冊的針對嚴重AKI患者的KOURAGE試驗